Categories
Pages
-

SmartMedCN

Archive for June, 2019

Opinions of the national basic medical system would be released

June 29th, 2019 | by

On September 19th, 2018, the State Council published “Guiding opinions on the improvement of the national basic medical system.” The “Guiding opinions” stipulates the establishment of a wholesome drug use monitoring platform and monitoring network system.It persists in centralized drug procurement, implements drug classification and acquisition; encourages local areas to combine basic drug system with classified medical treatment, family doctor contracting services and chronic disease health management so as to reduce the financial burden of patients. It establishes a wholesome national shortage of drug monitoring and early warning system, by the way of a reasonable purchase price, fixed-point production and unified distribution to ensure drug supply.

国家基本医药制度意见出台

来源:中国制药网 2018.09.19

核心提示:9月19日,国务院印发《关于完善国家基本医药制度的意见》。《意见》要求,建立健全的药品使用监测平台以及监测网络体系;坚持药品集中采购,落实药品分类采购;鼓励地方将基本药物制度与分级诊疗、家庭医生签约服务、慢性病健康管理结合,降低患者负担;建立健全的全国短缺药品监测预警系统,确定合理采购价格、定点生产、统一配送以保证药品供应。

Anhui establishes a Drug Quality and Security Traceability System for pharmaceutical enterprises

June 29th, 2019 | by

Recently, the Anhui Food and Drug Administration issued the “Guiding Opinions on the Construction of Drug Quality and Safety Traceability System for Pharmaceutical Enterprises in Anhui Province.” The “Guiding Opinions” clarify that pharmaceutical enterprises all over the province should establish a drug traceability system in accordance with laws and regulations. The traced information content of all links of the drug business should be true, accurate and complete, and should be saved at least for five years. For those who have not yet established a traceability system and for those traceability systems who do not operate effectively, especially when included incorrect information or incomplete information, it will be seriously investigated and dealt with following relevant laws and regulations.

安徽部署建立药品经营企业质量安全追溯体系

来源:中国医药报 2018.08.03

核心提示:日前,安徽省食品药品监管局印发《安徽省药品经营企业药品质量安全追溯体系建设指导意见》(以下简称《意见》)。《意见》明确,全省药品经营企业应按照法律法规建立药品追溯制度,药品经营各环节追溯信息内容应真实、准确、完整,且至少保存五年。对于没有建立追溯体系、追溯体系不能有效运行,特别是出现不真实信息或信息丢失的,将依照相关法律法规严肃查处。

Anhui: The 2018 version of the medical insurance catalog is released

June 19th, 2019 | by

Recently,  Anhui Human Resources and Social Security issued the “2018 version of Anhui Basic Medical Insurance, Work Injury Insurance and Drug List of Maternity Insurance”, which will be implemented from July, 1st, 2018. The catalog includes 1481 western medicines and 1356 Chinese patent medicines. Anhui Human Resources and Social Security indicates that Anhui Province will use the unified “Drug Catalog” database. The drugs on the catalog will be coded according to the “Social Insurance Drug Classification Code”, which will be confirmed by the provincial medical insurance administrative department .

安徽:2018版医保目录出炉

来源:中国医药报 2018.05.29

核心提示:日前,安徽省人社厅发布《安徽省基本医疗保险、工伤保险和生育保险药品目录2018年版》,将于7月1日起执行。该目录包括西药1481个,中成药1356个。安徽省人社厅表示,安徽省将使用统一的《药品目录》数据库,并按照《社会保险药品分类代码》对目录药品进行对码,由省级医保行政部门进行确认。

Enforcement regulation to reinforce confidentiality information supervision of drug examination and approval

June 19th, 2019 | by

Recently, the National Medical Products Administration published “Enforcement regulation to reinforce confidentiality information supervision of drug examination and approval”, which specifies four kinds of confidential information and thirteen circumstances of revealing confidential information. The “Enforcement regulation” asserts legal rights and interests of drug registration proposers, normalizes and reinforces the confidentiality management of examination and approval of information, in order to ensure the legality and high efficiency of the operation of drug examination and approval.

药品审评审批信息保密管理实施细则出台

来源:中国医药报 2018.05.22

核心提示:日前,国家药品监督管理局公布《关于加强药品审评审批信息保密管理的实施细则》(以下简称《实施细则》),明确了四类保密信息和13种泄露保密信息情形。《实施细则》维护了药品注册申请人的合法权益,规范和加强了审评审批信息保密管理,以确保药品审评审批工作合法高效运行。